Haemonetics (HAE) Q3 Earnings Meet Estimates
Portfolio Pulse from
Haemonetics (HAE) reported Q3 earnings of $1.19 per share, meeting the Zacks Consensus Estimate and showing growth from $1.04 per share a year ago.
February 06, 2025 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Haemonetics reported Q3 earnings of $1.19 per share, meeting expectations and showing growth from last year's $1.04 per share.
The earnings report met analyst expectations, which typically results in a neutral short-term stock price impact. The growth from last year is positive but already anticipated by the market.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100